Subvalvular aortic stenosis

disease
On this page

Summary

Subvalvular aortic stenosis (MONDO:0006987) is a disease with 1 cohort gene.

At a glance

  • Cohort genes: 1
  • ClinVar variants: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namesubvalvular aortic stenosis
Mondo IDMONDO:0006987
EFOEFO:1001199
MeSHD001020
DOIDDOID:5805
NCITC85172
SNOMED CT204368006
UMLSC0340375
MedGen90950
GARD0005052
MedDRA10042431
Is cancer (heuristic)no

Data availability: 1 ClinVar variant.

Disease family

An umbrella term covering 1 Mondo subtype.

Classification path: disease › human disease › disease by body system or component › cardiovascular disorderheart disorderheart valve disorderaortic valve disorderaortic valve stenosissubvalvular aortic stenosis

Related subtypes (3): supravalvular aortic stenosis, congenital aortic valve stenosis, childhood aortic valve stenosis

Subtypes (1): discrete subaortic stenosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

1 retrieved; paginated sample, class counts are floors:

1 uncertain significance

ClinVarVariant (HGVS)GeneClassificationReview
180340NM_004415.4(DSP):c.2550_2552dup (p.Leu851dup)DSPUncertain significancecriteria provided, multiple submitters, no conflicts

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 0 · Orphanet: 11 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
DSPOrphanet:154Familial isolated dilated cardiomyopathy
DSPOrphanet:158687Lethal acantholytic erosive disorder
DSPOrphanet:2032Idiopathic pulmonary fibrosis
DSPOrphanet:293165Skin fragility-woolly hair-palmoplantar keratoderma syndrome
DSPOrphanet:293888Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant
DSPOrphanet:293899Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant
DSPOrphanet:293910Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant
DSPOrphanet:369992Severe dermatitis-multiple allergies-metabolic wasting syndrome
DSPOrphanet:476096Erythrokeratodermia-cardiomyopathy syndrome
DSPOrphanet:50942Striate palmoplantar keratoderma
DSPOrphanet:65282Carvajal syndrome

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
DSPHGNC:3052ENSG00000096696P15924Desmoplakinclinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
DSPDesmoplakinA component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion.

Protein-family classification

Druggable: 0 · Difficult: 1 · Unknown: 0 · Druggable fraction: 0.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Scaffold/PPI117.3×0.058

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
DSPScaffold/PPInoPlectin_repeat, SH3_domain, Spectrin/alpha-actinin

Expression context

Cohort genes with no expression data: 0.

1 cohort gene are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
hair follicle1
skin of hip1
upper leg skin1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
DSP253ubiquitousmarkerskin of hip, upper leg skin, hair follicle

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
DSP2,897

Structural data

PDB: 1 · AlphaFold-only: 0 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
DSPP159244

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 6. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Apoptotic cleavage of cell adhesion proteins11038.2×0.006DSP
RND1 GTPase cycle1265.6×0.008DSP
RND3 GTPase cycle1259.6×0.008DSP
Formation of the cornified envelope187.8×0.017DSP
Keratinization155.7×0.022DSP
Neutrophil degranulation123.1×0.043DSP

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
ventricular compact myocardium morphogenesis12407.4×0.002DSP
bundle of His cell-Purkinje myocyte adhesion involved in cell communication12407.4×0.002DSP
desmosome organization12106.5×0.002DSP
protein localization to cell-cell junction11872.4×0.002DSP
peptide cross-linking11404.3×0.002DSP
regulation of ventricular cardiac muscle cell action potential11404.3×0.002DSP
epithelial cell-cell adhesion11203.7×0.002DSP
intermediate filament cytoskeleton organization1936.2×0.002DSP
adherens junction organization1510.7×0.003DSP
skin development1443.5×0.004DSP
regulation of heart rate by cardiac conduction1374.5×0.004DSP
keratinocyte differentiation1247.8×0.005DSP
intermediate filament organization1240.7×0.005DSP
wound healing1227.7×0.005DSP
epidermis development1210.7×0.005DSP
cell-cell adhesion1101.5×0.010DSP

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 1 of 1 evidence-associated genes (100%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
DSP00

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
DSP2Binding:2

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug1DSP

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
DSP2

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

  • Cohort genes: DSP